Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:
Welcome, Guest. Please login or register.
November 01, 2014, 12:21:02 AM

Login with username, password and session length

Members
Stats
  • Total Posts: 5310
  • Total Topics: 683
  • Online Today: 42
  • Online Ever: 204
  • (June 20, 2013, 05:15:21 AM)
Users Online
Users: 0
Guests: 27
Total: 27

Welcome

Welcome to the Hep Forums, a round-the-clock discussion area for people who have Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Another drug bites the dust  (Read 2653 times)

0 Members and 1 Guest are viewing this topic.

Offline worriedsilly

  • Member
  • Posts: 12
Another drug bites the dust
« on: September 26, 2012, 10:22:39 AM »
I keep reading about new hepc drugs failing. Is there still hope for new drugs with less side effects being availabe in the next year or two? I'm getting close to needing treatment and these failures are starting to freak me out.


Vertex ends work on one hepatitis C drug, continues another
http://ca.news.yahoo.com/vertex-ends-one-hepatitis-c-drug-continues-another-175205100--finance.html

Offline cookie610

  • Member
  • Posts: 8
Re: Another drug bites the dust
« Reply #1 on: September 28, 2012, 03:46:58 PM »
I thought these new classes were going to bring a bright new day to hep treatment. seems like they are all failing. this can't be good.

Offline Tim Horn

  • Member
  • Posts: 51
Re: Another drug bites the dust
« Reply #2 on: October 12, 2012, 01:23:35 PM »
One very important thing to remember is that the hepatitis C drug pipeline is very full with experimental agents and, just as has been the case with other infectious diseases (e.g., HIV), there will always be drugs that don't pan out because of limited effectiveness and safety concerns.

But yes, it does appear as if some of nucleoside/nucleotide polymerase inhibitors have been plagued by safety concerns. Fortunately, though, one of the agents that many are excited about -- Gilead's sofosbuvin (GS-7977) -- showed tremendous potential (with minimal side effects) in early studies and is now in the final stretch of studies needed for approval.

Also keep in mind, there are several other classes of drugs in Phase II and Phase III studies, including at least five NS5a inhibitors, ten protease inhibitors and seven non-nucleoside polymerase inhibitors.

There's a lot of potential in the hep C pipeline!

Tim Horn

Offline worriedsilly

  • Member
  • Posts: 12
Re: Another drug bites the dust
« Reply #3 on: October 12, 2012, 02:00:34 PM »
Thanks Tim.

I'll keep holding out hope something new will be available in time.

 


© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.